SightfileU.S. market data from official filings
Companies › ITRMF
ITERUM THERAPEUTICS PLC (ITRMF)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001659323 · EDGAR filings · Updated 2026-06-23
ITERUM THERAPEUTICS PLC (ITRMF) has reported institutional ownership of 2.9%, with 17 institutional managers holding positions valued at $41.3K per the latest 13F reporting period.
Institutional ownership
2.9%
Institutional managers
17
Reported 13F value
$41.3K
Insider activity
2 trans.
$13.0K net buying
Latest updates
- 2026-06-23 — 25-NSE filed
- 2026-03-31 — Current report (8-K) filed
- 2026-03-27 — Current report (8-K) filed
- 2026-03-03 — Current report (8-K) filed
- 2026-03-02 — Current report (8-K) filed
- 2026-02-18 — Current report (8-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ITERUM THERAPEUTICS PLC has 17 institutional holders and institutional ownership of 2.9%.
Insider activity
Insiders reported 2 transactions (2 buys, 0 sells) across 1 reporting insiders, with a net reported value of $13.0K.
Related companies
Check Cap Ltd (MBAI) · CLEARMIND MEDICINE INC (CMND) · Marimed Inc (MRMD) · GELTEQ LIMITED (GELS) · APTOSE BIOSCIENCES INC (APTOF) · Profusa Inc (PFSA)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-23.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-23.